ArticleBritish journal of pharmacology2013

Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with Modafinil.

M Uguen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.